Immediate application of frozen–thawed embryo transfer cycle in month following COVID‐19 infection does not impair subsequent pregnancy outcomes

Abstract Objectives To investigate whether immediate frozen embryo transfer (FET) in the next month following COVID‐19 recovery affects the subsequent pregnancy outcomes. Methods A retrospective cohort study was carried out at a university‐affiliated reproductive medicine center. The study group (post‐COVID‐19 group) consisted of women who were afflicted with COVID‐19 in December 2022 and immediately invested in FET in January 2023 after recovery, with embryos transferred and not exposed to the infection. The control group was composed of women treated during the pre‐COVID‐19 period (January 2019). Multivariable logistic regression analyses as well as a propensity score matching (PSM) approach were introduced to control for the potential confounders and selection bias. Results A total of 200 patients were included in the post‐COVID‐19 group while a total of 641 women were enrolled in the control group. The rate of ongoing pregnancy was comparable between the study cohorts in both the unadjusted and confounder‐adjusted logistic regression models. The other reproductive outcomes, including the odds of the positive pregnancy test, implantation, clinical pregnancy, and early pregnancy loss were all similar between the comparison groups. Results from PSM models further confirmed the lack of significant differences in pregnancy outcomes between the post‐COVID‐19 group versus the control group. Conclusion Our findings suggested that for patients who get infected with COVID‐19, the immediate investment in a FET cycle in the next month after recovery did not seem to compromise the ongoing pregnancy outcomes in cases of transferred embryos resulting from the pre‐infection stage. Thus, women who had frozen embryos from the pre‐infection cycles should be counseled and encouraged to invest in IVF as soon as possible after recovering from COVID‐19 infection. This article is protected by copyright. All rights reserved.